Study to Investigate Efficacy and Safety of a New Oral Contraceptive
NCT00185289
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1392
Enrollment
INDUSTRY
Sponsor class
Conditions
Contraception
Interventions
DRUG:
EV/DNG (Qlaira, BAY86-5027, SH T00658K)
Sponsor
Bayer